Author: Vassallo, Ralph R.; Bravo, Marjorie D.; Kamel, Hany
Title: Pandemic blood donor demographics – Do changes impact blood safety? Cord-id: az7cq7an Document date: 2021_2_20
ID: az7cq7an
Snippet: BACKGROUND: COVIDâ€19 safety measures and possibly SARSâ€CoVâ€2 antibody testing may alter blood donor demography, which has the potential to alter blood safety. We characterized preâ€pandemic and pandemic rates of donor infectious disease marker (IDM) reactivity which reflect the residual risk of transfusionâ€transmitted infections (TTIs) undetectable by current testing. METHODS: This crossâ€sectional analysis of allogeneic blood donor presentations and successful donations in a large nat
Document: BACKGROUND: COVIDâ€19 safety measures and possibly SARSâ€CoVâ€2 antibody testing may alter blood donor demography, which has the potential to alter blood safety. We characterized preâ€pandemic and pandemic rates of donor infectious disease marker (IDM) reactivity which reflect the residual risk of transfusionâ€transmitted infections (TTIs) undetectable by current testing. METHODS: This crossâ€sectional analysis of allogeneic blood donor presentations and successful donations in a large national US blood collector identifies changes in selfâ€reported behavioral risk factors and IDM reactivity. Data on allogeneic blood donor presentations and successful donations from March 1 through August 31, 2020 and the same period in 2019 were retrieved from the blood center's computer system. Donor demographics and deferrals for reported behavioral risk factors and confirmedâ€positive IDMs were compared in preâ€pandemic and pandemic periods. RESULTS: With increasing mobile blood drive cancellations, pandemic donors were more likely than 2019 donors to be female, over age 30, nonâ€Hispanic Whites, and have a postâ€secondary degree. Firstâ€time donations (at highest risk for confirmedâ€positive IDMs) did not substantially increase. Pandemic donors reported fewer behavioral risks and IDMs declined among these donors. Midâ€pandemic introduction of screening for SARSâ€CoVâ€2 antibodies did not affect IDM rates. CONCLUSIONS: Unlike disasters, which tend to bring out more firstâ€time donors with increased IDM reactivity and TTI residual risk, COVIDâ€19 donors had lower IDM rates which were not affected by SARSâ€CoVâ€2 antibody testing. Alreadyâ€low TTI residual risk is likely to have declined as a result.
Search related documents:
Co phrase search for related documents- acid testing and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- acute respiratory and lymphotrophic virus: 1, 2, 3
- acute respiratory syndrome and lymphotrophic virus: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date